Clinical Case Reports

A case of myeloproliferative neoplasm-associated glomerulopathy in a patient with myelofibrosis

Biomedicines

Clinical and molecular insights of arterial and venous thrombosis in myeloproliferative diseases-case-based narrative review

Blood Neoplasia

Final safety and efficacy results from a phase 1/2 study of tagraxofusp, a CD123-targeted therapy, for myelofibrosis

Thrombosis Research

Prothrombotic profiles in myelofibrosis: Fibrinogen oxidation and the beneficial effects of ruxolitinib

Tomography

Fat fraction MRI for longitudinal assessment of bone marrow heterogeneity in a mouse model of myelofibrosis

Frontiers in Oncology

Durable response to venetoclax, azacytidine, and ruxolitinib in chronic-phase myelofibrosis resistant to ruxolitinib: A case report and literature review

Blood

Novel strategies targeting mutant calreticulin in essential thrombocythemia and myelofibrosis

European Journal of Haematology

Efficacy of momelotinib in myelofibrosis patients: Results from a multicenter study

European Journal of Haematology

Final results from a large, non-interventional, phase 4 study of ruxolitinib for the treatment of myelofibrosis in clinical routine

Transplantation and Cellular Therapy

Risk stratification using DIPSS and splenomegaly in myelofibrosis treated with pre-transplant JAK inhibitors